Cleared Traditional

K980631 - EMBOL-X AORTIC OCCLUSION AND CARDIOPLEGIA CANNULA

K980631 is an FDA 510(k) clearance for EMBOL-X AORTIC OCCLUSION AND CARDIOPLEG..., manufactured by Embol-X, Inc.. The device is a Class 2 Cardiovascular device with product code DXC cleared through the Traditional 510(k) pathway after a 349-day FDA review.

K980631 · Embol-X, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1999
Decision
349d
Days
Class 2
Risk

K980631 is an FDA 510(k) clearance for the EMBOL-X AORTIC OCCLUSION AND CARDIOPLEGIA CANNULA. Classified as Clamp, Vascular (product code DXC), Class II - Special Controls.

Submitted by Embol-X, Inc. (Mountain View, US). The FDA issued a Cleared decision on February 2, 1999 after a review of 349 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Embol-X, Inc. devices

FDA 510(k) Submission Details - K980631

510(k) Number K980631 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 18, 1998
Decision Date February 02, 1999
Days to Decision 349 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
224d slower than avg
Panel avg: 125d · This submission: 349d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXC Device Classification - Class 2, Special Controls

Product Code DXC Clamp, Vascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXC Clamp, Vascular

All 159
Devices cleared under the same product code (DXC) and FDA review panel - the closest regulatory comparables to K980631.
MICRINS MICRO ANASTOMOSIS CLAMP
K982278 · Micrins Surgical, Inc. · Mar 1999
ESTECH ARTERIAL REMOTE ACCESS PERFUSION CANNULA
K990573 · Estech, Inc. · Mar 1999
FEMOSTOP COMPRESSION ARCH, FEMOSTOP PUMP, FEMOSTOP BILATERAL ADAPTER
K983471 · Radi Medical Systems AB · Feb 1999
FEMOSTOP II PLUS DISPOSABLE SET MODEL 11166, FEMOSTOP II PLUS COMPRESSION ARCH MODEL 11168, FEMOSTOP II BILATERAL ADAPT0
K982182 · Radi Medical Systems AB · Sep 1998
CAOW HEMOSTASIS SYSTEM
K972689 · Anlam Corp. · Aug 1998
FLO-THRU
K981624 · Bio-Vascular, Inc. · Aug 1998